J Duval

2.6k total citations
82 papers, 2.1k citations indexed

About

J Duval is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, J Duval has authored 82 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Medicine, 39 papers in Pharmacology and 27 papers in Infectious Diseases. Recurrent topics in J Duval's work include Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Antimicrobial Resistance in Staphylococcus (24 papers). J Duval is often cited by papers focused on Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Antimicrobial Resistance in Staphylococcus (24 papers). J Duval collaborates with scholars based in France, Germany and Italy. J Duval's co-authors include Patrice Courvalin, Roland Leclercq, Jacques Tankovic, Sylvie Dutka‐Malen, E Derlot, Marc Galimand, Bruno Périchon, Pierre Legrand, Yael Costa and Christian Brun‐Buisson and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J Duval

77 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Duval France 24 1.1k 711 594 583 477 82 2.1k
B E Murray United States 20 1.6k 1.4× 472 0.7× 773 1.3× 604 1.0× 590 1.2× 27 2.3k
C N Baker United States 26 758 0.7× 455 0.6× 469 0.8× 473 0.8× 629 1.3× 66 2.5k
Jean Duval France 5 991 0.9× 491 0.7× 580 1.0× 377 0.6× 326 0.7× 9 1.6k
Linda M. Weigel United States 20 1.0k 0.9× 883 1.2× 520 0.9× 901 1.5× 545 1.1× 30 2.5k
E Derlot France 8 1.3k 1.1× 340 0.5× 719 1.2× 447 0.8× 309 0.6× 17 1.7k
S Handwerger United States 22 1.3k 1.2× 285 0.4× 593 1.0× 557 1.0× 491 1.0× 33 2.0k
F. H. Kayser Switzerland 36 2.0k 1.8× 1.1k 1.6× 753 1.3× 1.4k 2.4× 693 1.5× 104 3.6k
C Thornsberry United States 32 627 0.6× 1.2k 1.6× 513 0.9× 526 0.9× 916 1.9× 111 3.1k
D.F. Sahm United States 28 1.6k 1.4× 1.3k 1.8× 979 1.6× 608 1.0× 974 2.0× 56 3.4k
Lenore L. Carias United States 26 935 0.8× 548 0.8× 353 0.6× 481 0.8× 251 0.5× 43 1.7k

Countries citing papers authored by J Duval

Since Specialization
Citations

This map shows the geographic impact of J Duval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Duval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Duval more than expected).

Fields of papers citing papers by J Duval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Duval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Duval. The network helps show where J Duval may publish in the future.

Co-authorship network of co-authors of J Duval

This figure shows the co-authorship network connecting the top 25 collaborators of J Duval. A scholar is included among the top collaborators of J Duval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Duval. J Duval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schito, Gian Carlo, J. F. Acar, A. Bauernfeind, et al.. (1996). A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. Journal of Antimicrobial Chemotherapy. 38(4). 627–639. 7 indexed citations
2.
Duval, J, C J Soussy, J. F. Acar, et al.. (1993). In-vitro antibacterial activity of cefepime: a multicentre study. Journal of Antimicrobial Chemotherapy. 32(suppl B). 55–61. 24 indexed citations
3.
Leclercq, Roland, et al.. (1993). Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrobial Agents and Chemotherapy. 37(10). 2119–2125. 105 indexed citations
4.
Leclercq, Roland, Régis Bismuth, & J Duval. (1992). New high-content disks for determination of high-level aminoglycoside resistance in clinical isolates ofEnterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases. 11(4). 356–360. 8 indexed citations
5.
Leclercq, Roland, Sylvie Dutka‐Malen, A Brisson-Noël, et al.. (1992). Resistance of Enterococci to Aminoglycosides and Glycopeptides. Clinical Infectious Diseases. 15(3). 495–501. 93 indexed citations
6.
Soussy, Claude–James, J. F. Acar, R Cluzel, et al.. (1992). A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. Journal of Antimicrobial Chemotherapy. 30(suppl A). 53–58. 26 indexed citations
7.
Legrand, Pierre, G. Fournier, A Buré, et al.. (1989). Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals. European Journal of Clinical Microbiology & Infectious Diseases. 8(6). 527–529. 62 indexed citations
8.
Leclercq, Roland, et al.. (1989). Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 33(1). 10–15. 254 indexed citations
9.
Leclercq, Roland, et al.. (1988). [In vitro antibacterial activity of piperacillin/quinolone combinations].. PubMed. 36(5). 357–60. 3 indexed citations
10.
Leclercq, Roland, A Brisson-Noël, J Duval, & Patrice Courvalin. (1987). Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp. Antimicrobial Agents and Chemotherapy. 31(12). 1887–1891. 34 indexed citations
11.
Deforges, Lionel, et al.. (1986). [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].. PubMed. 34(5 Pt 2). 631–3. 3 indexed citations
12.
Duval, J, et al.. (1986). [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].. PubMed. 34(5 Pt 2). 561–6. 2 indexed citations
13.
Leclercq, Roland, C Carlier, J Duval, & Patrice Courvalin. (1985). Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy. 28(3). 421–424. 35 indexed citations
14.
Deforges, Lionel, C.-J. Soussy, & J Duval. (1984). [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria].. PubMed. 32(5 Pt 2). 496–500.
15.
Deforges, Lionel, C J Soussy, J Duval, et al.. (1983). [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].. PubMed. 31(5). 375–8. 1 indexed citations
16.
Jp, Vernant, C Cordonnier, Bernard Brun, et al.. (1983). [Bacterial septicemia in neutropenia patients].. PubMed. 134(7). 629–35. 5 indexed citations
17.
Soussy, C.-J., et al.. (1980). Cefotaxime concentration in the bile and wall of the gallbladder. Journal of Antimicrobial Chemotherapy. 6(suppl A). 125–130. 18 indexed citations
18.
Rapin, M, et al.. (1975). [Septicemias of superinfection in resucitation. Their prevention by restriction of antibiotics].. PubMed. 4(7). 483–6. 1 indexed citations
19.
Duval, J, M. Mora, & Claude–James Soussy. (1974). Pharmacocinétique d'une nouvelle céphalosporine: La céphacétrile taux sériques et urinaires chez l'adulte et le prématuré diffusion méningée et passage transplacentaire. Médecine et Maladies Infectieuses. 4(5). 221–229. 2 indexed citations
20.
Duval, J, et al.. (1971). [Antibiotic associations on acting Pseudomonas aeruginosa].. PubMed. 19(11). 637–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026